Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology

por Eldi, Preethi, Cooper, Tamara H., Liu, Liang, Prow, Natalie A., Diener, Kerrilyn R., Howley, Paul M., Suhrbier, Andreas, Hayball, John D.
Publicado 2017

The vaccinia‐based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses

por Eldi, Preethi, Cooper, Tamara H, Prow, Natalie A, Liu, Liang, Heinemann, Gary K, Zhang, Voueleng J, Trinidad, Abigail D, Guzman‐Genuino, Ruth Marian, Wulff, Peter, Hobbs, Leanne M, Diener, Kerrilyn R, Hayball, John D
Publicado 2022

The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates

por Prow, Natalie A., Liu, Liang, McCarthy, Mary K., Walters, Kevin, Kalkeri, Raj, Geiger, Jillian, Koide, Fusataka, Cooper, Tamara H., Eldi, Preethi, Nakayama, Eri, Diener, Kerrilyn R., Howley, Paul M., Hayball, John D., Morrison, Thomas E., Suhrbier, Andreas
Publicado 2020

A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses

por Prow, Natalie A., Liu, Liang, Nakayama, Eri, Cooper, Tamara H., Yan, Kexin, Eldi, Preethi, Hazlewood, Jessamine E., Tang, Bing, Le, Thuy T., Setoh, Yin Xiang, Khromykh, Alexander A, Hobson-Peters, Jody, Diener, Kerrilyn R., Howley, Paul M., Hayball, John D., Suhrbier, Andreas
Publicado 2018

Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models

por Nguyen, Wilson, Nakayama, Eri, Yan, Kexin, Tang, Bing, Le, Thuy T., Liu, Liang, Cooper, Tamara H., Hayball, John D., Faddy, Helen M., Warrilow, David, Allcock, Richard J. N., Hobson-Peters, Jody, Hall, Roy A., Rawle, Daniel J., Lutzky, Viviana P., Young, Paul, Oliveira, Nidia M., Hartel, Gunter, Howley, Paul M., Prow, Natalie A., Suhrbier, Andreas
Publicado 2020